BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29151933)

  • 1. Expression of ARID1B Is Associated With Poor Outcomes and Predicts the Benefit from Adjuvant Chemotherapy in Bladder Urothelial Carcinoma.
    Wang B; Xie H; Ma C; Zhang G; Gan H; Wang Q; Liu X; Zhu Y; Zhu Y; Shi G; Zhang H; Dai B; Shen Y; Ye D
    J Cancer; 2017; 8(17):3490-3497. PubMed ID: 29151933
    [No Abstract]   [Full Text] [Related]  

  • 2. ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma.
    Sato E; Nakayama K; Razia S; Nakamura K; Ishikawa M; Minamoto T; Ishibashi T; Yamashita H; Iida K; Kyo S
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis.
    Madan V; Shyamsunder P; Dakle P; Woon TW; Han L; Cao Z; Nordin HBM; Jizhong S; Shuizhou Y; Hossain MZ; Koeffler HP
    Blood Adv; 2023 Nov; 7(21):6553-6566. PubMed ID: 37611161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated expression of AT-rich interactive domain-containing protein 1B predicts poor prognosis in patients with triple-negative breast cancer.
    Cui Y; Bai X; Niu M; Qin Y; Zhang X; Pang D
    Oncol Lett; 2019 Mar; 17(3):3289-3295. PubMed ID: 30867762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARID1B is a specific vulnerability in ARID1A-mutant cancers.
    Helming KC; Wang X; Wilson BG; Vazquez F; Haswell JR; Manchester HE; Kim Y; Kryukov GV; Ghandi M; Aguirre AJ; Jagani Z; Wang Z; Garraway LA; Hahn WC; Roberts CW
    Nat Med; 2014 Mar; 20(3):251-4. PubMed ID: 24562383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden.
    Naito T; Udagawa H; Umemura S; Sakai T; Zenke Y; Kirita K; Matsumoto S; Yoh K; Niho S; Tsuboi M; Ishii G; Goto K
    Lung Cancer; 2019 Dec; 138():35-42. PubMed ID: 31630044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and prognostic significance of SWI/SNF complex subunits in undifferentiated gastric carcinoma.
    Zhang Z; Li Q; Sun S; Li Z; Cui ZG; Zhang M; Liu Q; Zhang Y; Xiong S; Zhang S
    World J Surg Oncol; 2022 Dec; 20(1):383. PubMed ID: 36464671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
    Garczyk S; Schneider U; Lurje I; Becker K; Vögeli TA; Gaisa NT; Knüchel R
    PLoS One; 2018; 13(8):e0202965. PubMed ID: 30138427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stage-dependent prognostic role of
    Zhou H; Sun D; Miao C; Tao J; Ge C; Chen T; Li H; Hou H
    Transl Cancer Res; 2023 Nov; 12(11):3088-3104. PubMed ID: 38130310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Evolutionary Conserved SWI/SNF Subunits ARID1A and ARID1B Are Key Modulators of Pluripotency and Cell-Fate Determination.
    Pagliaroli L; Trizzino M
    Front Cell Dev Biol; 2021; 9():643361. PubMed ID: 33748136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting ARID1A-mutant colorectal cancer: depletion of ARID1B increases radiosensitivity and modulates DNA damage response.
    Niedermaier B; Sak A; Zernickel E; Xu S; Groneberg M; Stuschke M
    Sci Rep; 2019 Dec; 9(1):18207. PubMed ID: 31796878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.
    Kelso TWR; Porter DK; Amaral ML; Shokhirev MN; Benner C; Hargreaves DC
    Elife; 2017 Oct; 6():. PubMed ID: 28967863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines.
    Khursheed M; Kolla JN; Kotapalli V; Gupta N; Gowrishankar S; Uppin SG; Sastry RA; Koganti S; Sundaram C; Pollack JR; Bashyam MD
    Br J Cancer; 2013 May; 108(10):2056-62. PubMed ID: 23660946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological significance of ARID1B in breast invasive ductal carcinoma.
    Shao F; Guo T; Chua PJ; Tang L; Thike AA; Tan PH; Bay BH; Baeg GH
    Histopathology; 2015 Nov; 67(5):709-18. PubMed ID: 25817822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undifferentiated Endometrial Carcinomas Show Frequent Loss of Core Switch/Sucrose Nonfermentable Complex Proteins.
    Köbel M; Hoang LN; Tessier-Cloutier B; Meng B; Soslow RA; Stewart CJR; Lee CH
    Am J Surg Pathol; 2018 Jan; 42(1):76-83. PubMed ID: 28863077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARID1A upregulation predicts better survival in patients with urothelial bladder carcinoma.
    Cao Q; Wang C; Ding Y; Xu D; Qian S; Shen H; Qi J
    J Int Med Res; 2020 Apr; 48(4):300060519895687. PubMed ID: 31891283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA Display Identifies Potent, Paralog-Selective Peptidic Ligands for ARID1B.
    Cremosnik GS; Mesrouze Y; Zueger P; Furkert D; Grandjean F; Argoti D; Mermet-Meillon F; Bauer MR; Brittain S; Rogemoser P; Yang W; Giovannoni J; McGregor L; Tang J; Knapp M; Holzinger S; Buhr S; Muller L; Leder L; Xie L; Fernandez C; Nieto-Oberhuber C; Chène P; Galli GG; Sesterhenn F
    ACS Chem Biol; 2024 May; 19(5):1142-1150. PubMed ID: 38655884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SWI/SNF complex gene variations are associated with a higher tumor mutational burden and a better response to immune checkpoint inhibitor treatment: a pan-cancer analysis of next-generation sequencing data corresponding to 4591 cases.
    Li Y; Yang X; Zhu W; Xu Y; Ma J; He C; Wang F
    Cancer Cell Int; 2022 Nov; 22(1):347. PubMed ID: 36371186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder.
    Kaushik D; Frank I; Boorjian SA; Cheville JC; Eisenberg MS; Thapa P; Tarrell RF; Thompson RH
    Int J Urol; 2015 Jun; 22(6):549-54. PubMed ID: 25761779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.
    Coatham M; Li X; Karnezis AN; Hoang LN; Tessier-Cloutier B; Meng B; Soslow RA; Blake Gilks C; Huntsman DG; Stewart CJ; Postovit LM; Köbel M; Lee CH
    Mod Pathol; 2016 Dec; 29(12):1586-1593. PubMed ID: 27562491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.